A Study of Novel Anti-CD19 CAR-T in Patients With r/r B-Cell Malignancies

NCT05932173 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
60
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

920th Hospital of Joint Logistics Support Force of People's Liberation Army of China